Neuropharmacology and Therapeutic Development

Neuropharmacology is the study of how drugs affect the nervous system, aiming to develop treatments for neurological and psychiatric disorders. This field has seen significant advancements, particularly in the development of therapies targeting diseases such as Alzheimer's, Parkinson's, epilepsy, and multiple sclerosis. Neuropharmacological research focuses on understanding the molecular mechanisms of the brain and nervous system to create more effective and targeted therapies with fewer side effects. One of the key challenges in neuropharmacology is the blood-brain barrier (BBB), which limits the delivery of therapeutic agents to the brain. Researchers are exploring innovative drug delivery systems, such as nanoparticles, to overcome this barrier and improve drug efficacy. Furthermore, advancements in gene therapy and personalized medicine hold the potential to revolutionize neuropharmacology by offering treatments tailored to individual genetic profiles.

    Related Conference of Neuropharmacology and Therapeutic Development

    February 24-25, 2025

    11th International Conference on Surgeons

    Madrid, Spain
    May 19-20, 2025

    10th International Conference on Surgery and Anaesthesia

    Zurich, Switzerland
    June 25-26, 2025

    5th World Congress on Surgery

    London, UK
    July 21-22, 2025

    8th World Congress on Surgeons

    Barcelona, Spain
    November 19-20, 2025

    16th European Conference on Surgery & Cosmetology

    Barcelona, Spain
    December 04-05, 2025

    8th Annual Summit on Surgery and Transplantation

    Paris, France

    Neuropharmacology and Therapeutic Development Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in